Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors
- Resource Type
- Journal
- Authors
- Li, Huiping; Liu, Rongrui; Shao, Bin; Ran, Ran; Song, Guohong; Wang, Ke; Shi, Yehui; Liu, Jihong; Hu, Wenjing; Chen, Fu; Liu, Xiaoran; Zhang, Gairong; Zhao, Chuanhua; Jia, Ru; Wang, Quanren; Rugo, Hope S.; Zhang, Yifan; Li, Guangze; Xu, Jianming
- Source
- CHINESE JOURNAL OF CANCER RESEARCH; JUN 2020, 32 3, p370-p+, 15p.
- Subject
- Language
- English
- ISSN
- 19930631